• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Tenaris SA ADR

Tenaris SA ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. WICT Southeast Announces Winners of the 13th Annual Red Letter Awards

    WICT Southeast Announces Winners of the 13th Annual Red Letter Awards

  2. Top 6 Vendors in the Global Automotive Tiptronic Transmission Market during 2016 to 2020, from Technavio

    Top 6 Vendors in the Global Automotive Tiptronic Transmission Market during 2016 to 2020, from Technavio

  3. Surviving an FDA Inspection: Understand the Do's and Don'ts and the Ground Rules - Research and Markets

    Surviving an FDA Inspection: Understand the Do's and Don'ts and the Ground Rules - Research and Markets

  4. UPDATE: Facebook's Mark Zuckerberg may have a Bieber problem on his hands

    UPDATE: Facebook's Mark Zuckerberg may have a Bieber problem on his hands

  5. Global Head and Neck Cancer Market Study 2016: Revenues from new brands will offset the biosimilar and generic erosion of Erbitux and TS -1 - Research and Markets

    Global Head and Neck Cancer Market Study 2016: Revenues from new brands will offset the biosimilar and generic erosion of Erbitux and TS -1 - Research and Markets

  6. UPDATE: What to watch for in Gap earnings

    UPDATE: What to watch for in Gap earnings

  7. What to watch for in Gap earnings

    What to watch for in Gap earnings

  8. IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces An Investigation of Claims against Quorum Health Corporation And Strongly Encourages Investors To Contact The Firm

    IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces An Investigation of Claims against Quorum Health Corporation And Strongly Encourages Investors To Contact The Firm

  9. INVESTOR ALERT: Goldberg Law PC Announces An Investigation of Claims against Quorum Health Corporation And Strongly Encourages Investors To Contact The Firm

    INVESTOR ALERT: Goldberg Law PC Announces An Investigation of Claims against Quorum Health Corporation And Strongly Encourages Investors To Contact The Firm

  10. Global Colorectal Cancer Market Report 2016: What kind of impact will Merck's PD-1 inhibitor Keytruda have in this indication? - Research and Markets

    Global Colorectal Cancer Market Report 2016: What kind of impact will Merck's PD-1 inhibitor Keytruda have in this indication? - Research and Markets

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.